I agree. As I posted earlier, I hope Hartman and LaBorde are working overtime right now. The timing to launch a non-opiod pain reliever is perfect. They just need to get it done and soon. If this company can get these patches and other products to market with even decent sales, dilution will be history, paying for cancer R&D will happen and the BIEI market cap will soar IMO. We don't need any fluff right now. We need business men concentrating on making money with the company's line of pain relief products.
News 
Market Data 
Discover 
AI
